XAIR
Beyond Air Inc
NASDAQ: XAIR · HEALTHCARE · MEDICAL DEVICES
$0.53
+5.04% today
Updated 2026-04-30
Market cap
$5.36M
P/E ratio
—
P/S ratio
0.77x
EPS (TTM)
$-4.47
Dividend yield
—
52W range
$0 – $6
Volume
0.3M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$8.67
+1550.80%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 104.70% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.25M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $145190.00 | $59000.00 | $1.16M | $3.71M | $6.92M |
| Net income | $-43.18M | $-55.82M | $-60.24M | $-46.63M | $-7.34M |
| EPS | — | — | — | — | $-4.47 |
| Free cash flow | $-24.58M | $-36.89M | $-61.76M | $-44.10M | $-4.25M |
| Profit margin | -29,738.27% | -94,603.39% | -5,197.76% | -1,258.43% | — |
Peer comparison
Smart narrative
Beyond Air Inc trades at $0.53. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $6.92M.
Frequently asked questions
What is Beyond Air Inc's stock price?
Beyond Air Inc (XAIR) trades at $0.53.
Is Beyond Air Inc overvalued?
Smart Value Score 44/100 (Grade D, Sell).
What is the price target of Beyond Air Inc (XAIR)?
The analyst target price is $8.67, representing +1550.8% upside from the current price of $0.53.
What is Beyond Air Inc's revenue?
TTM revenue is $6.92M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.77x
ROE-240.20%
Beta0.53
50D MA$0.76
200D MA$1.64
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—